A judge has declassed one of three class actions against Monsanto over its allegedly cancer-causing weedkiller and chosen the proceedings brought by heavyweight plaintiff-firm Maurice Blackburn to go first, while seeking to appease the competing firmâs fear of being âswallowedâ by a larger rival.
The top judge of the Federal Court plans to clear the schedules of three judges at the start of next year so they can hear and decide Johnson & Johnson’s challenge of a class action ruling that found its pelvic mesh devices were defective and awarded the lead applicants $2.6 million in damages.
The identity of a Big Six partner to whom a former AMP lawyer allegedly criticised her superior has been revealed in court during a heated exchange between the barristers in the unfair dismissal proceeding.
Law firm Mills Oakley and a firm partner are facing a lawsuit alleging they violated their duty of care by transferring nearly $1 million in client funds to the wrong account after being duped by false emails purporting to be from a representative of one of the firm’s clients.
ISignthis has come up short in its courtroom bid to block publication of the Australian Stock Exchange’s “damaging” reasons for suspending its shares.
The Queensland government is seeking court orders that put dam operators Seqwater and Sunwater on the hook for the vast majority of damages after a class action judgment found negligence in the lead up to the state’s 2011 floods that destroyed 2,000 homes.
The COVID-19 pandemic and government social distancing restrictions were reasons to be flexible in applying and adapting the law, the judge overseeing the administration of Virgin Australia has said in exempting administrators from liability for unpaid leases and allowing Thursday’s meeting of the airlines’ creditors to be held by teleconference.
A former privacy regulator will investigate a data breach by the Federal Court that exposed the real names of hundreds of asylum seekers on its website.
A law firm with a global footprint is facing a possible breach of trust lawsuit in relation to $27 million it held as security for costs in an international arbitration.
A court has dismissed a claim by the Australian Government for $325 million against pharmaceutical companies Sanofi and Bristol-Myers Squibb allegedly owed for excess subsidies it paid for blood-thinner Plavix as a result of an interlocutory injunction blocking a generic version of the blockbuster drug.